top of page
South Bay Retina (2).png

Retinitis Pigmentosa: Symptoms, Causes, Diagnosis, and Treatment

Nov 10
5 min read

Retinitis pigmentosa, often shortened to RP, is not one single disease.

It is a group of inherited retinal disorders that gradually damage the light-sensitive cells of the retina.

The earliest signs often involve difficulty seeing in dim light and gradual loss of peripheral vision. The speed, age of onset, and amount of vision affected vary widely because many different genes cause RP.



1. What is retinitis pigmentosa?


RP belongs to a group of conditions known as inherited retinal diseases.

In many forms, rod photoreceptors are affected first. Rods are especially important for night vision and peripheral vision.

As the condition progresses, cone photoreceptors sometimes become involved as well. Cones support central detail and color vision.


2. What are the first symptoms of RP?


Night blindness is one of the most common early symptoms.

A person might struggle to move from a bright room into a dark one, have difficulty seeing in a dim restaurant or movie theater, or feel less confident driving at dusk.

Peripheral vision loss often follows or develops alongside night-vision problems.


3. What does peripheral vision loss feel like?


Peripheral vision is what you see to the sides while looking straight ahead.

Early loss is sometimes subtle. People bump into furniture, miss objects on the floor, or fail to notice someone approaching from the side.

As the field narrows further, some patients describe tunnel vision.


4. Does RP affect central vision?


Central vision often remains useful longer than peripheral vision, but this varies by genetic form and stage.

Later involvement of cone cells, macular changes, cataracts, or cystic swelling in the retina sometimes reduces central detail.

Reading and recognizing faces become harder when central vision is affected.


5. Can RP affect color vision?


Yes. Color discrimination sometimes declines as cone function becomes affected.

This generally occurs later than the classic night-vision and peripheral-field symptoms.


6. What causes retinitis pigmentosa?


RP is genetic.

Changes in genes involved in retinal function lead to gradual photoreceptor dysfunction and degeneration.

More than 100 genes are associated with forms of RP, which helps explain why the condition looks different from one person to another.


7. Does everyone with RP have a family history?


No.

RP follows several inheritance patterns, and some people are the first known person in their family to receive the diagnosis.

A missing family history does not rule out a genetic retinal disease.


8. Why is genetic testing important?


Genetic testing sometimes identifies the gene responsible for the retinal disease.

This helps confirm the diagnosis, clarify inheritance, inform family counseling, and identify whether a person matches an approved gene-specific treatment or a clinical trial.

A negative or inconclusive test does not automatically exclude RP because not every disease-causing change is detected by every test.


9. How is RP diagnosed?


Diagnosis combines symptoms, family history, retinal examination, imaging, and functional testing.

The exact testing plan varies by age, stage, and suspected genetic form.

  • dilated retinal examination

  • optical coherence tomography, or OCT

  • visual field testing

  • electroretinography, or ERG

  • fundus photography or autofluorescence

  • genetic testing


10. What does an ERG test measure?


Electroretinography measures the electrical response of the retina to light.

Full-field ERG provides information about rod and cone function across much of the retina.

This is especially useful when the doctor needs objective evidence of widespread photoreceptor dysfunction.


11. What does OCT show in RP?


OCT creates cross-sectional images of the retina.

It helps the specialist examine the photoreceptor layers, measure structural change, and identify complications such as cystic macular swelling or an epiretinal membrane.

Repeat OCT also provides a useful comparison over time.


12. Why is visual field testing important?


Visual field testing measures how much central and peripheral vision remains.

Because RP often begins outside the center, field testing sometimes shows functional loss that a standard letter chart does not capture.

It also helps document progression and practical limitations.


13. Is there a cure for retinitis pigmentosa?


There is no single cure for the many genetic forms of RP.

Treatment depends on the specific genetic cause, stage of disease, and complications.

Research is active, but most investigational therapies are still being studied for safety and effectiveness.


14. Is there an FDA-approved gene therapy for RP?


There is an FDA-approved gene therapy for a specific inherited retinal condition caused by confirmed mutations in both copies of the RPE65 gene.

The treatment is voretigene neparvovec-rzyl, sold as LUXTURNA.

It is not a general treatment for every form of RP. Eligibility requires a confirmed biallelic RPE65 mutation and enough viable retinal cells for treatment.


15. What treatments help if your RP is not RPE65-related?


For most genetic forms of RP, management focuses on preserving useful vision, treating associated eye problems, and supporting daily function.

Low-vision rehabilitation, mobility training, magnification, lighting strategies, and assistive technology often make a meaningful difference.

Treatable complications such as cataracts or retinal swelling should also be addressed when appropriate.


16. Should people with RP take vitamin A?


Do not start high-dose vitamin A specifically for RP without specialist advice.

Current American Academy of Ophthalmology guidance does not recommend routine vitamin A supplementation for RP because evidence of benefit is not substantial and excessive vitamin A creates health risks.

Supplements are not a substitute for genetic evaluation and retinal follow-up.


17. Why are regular eye examinations important?


RP progresses differently from person to person.

Follow-up helps track visual function, monitor structural changes, treat complications, and update patients about new research or trial opportunities.

Inherited retinal disease care changes as genetic testing and treatment options evolve.


18. What other eye problems occur with RP?


People with RP sometimes develop other conditions that affect vision separately from the inherited degeneration.

  • cataracts

  • cystic macular swelling

  • refractive errors

  • epiretinal membrane

  • reduced contrast sensitivity

  • light sensitivity


19. What is happening in RP research?


Researchers are studying gene replacement, gene editing, RNA-based treatments, neuroprotective approaches, optogenetics, cell therapy, and other strategies.

Most remain investigational.

Knowing the specific genetic diagnosis often matters because many clinical trials enroll patients based on the affected gene, stage of disease, age, or remaining retinal structure.


20. What should family members know?


Because RP is inherited, relatives sometimes benefit from a discussion about family history, genetic counseling, and whether testing is appropriate.

Inheritance patterns vary, so the chance of another family member being affected depends on the gene and how the condition is passed through the family.


What this means for your vision


Retinitis pigmentosa is a broad group of inherited retinal diseases rather than one uniform condition.

Night blindness and peripheral vision loss are classic early features, but the age of onset and rate of progression vary widely.

A detailed retinal evaluation and genetic testing help define the diagnosis, identify treatable complications, and determine whether gene-specific treatment or research opportunities are relevant.


Book with South Bay Retina


South Bay Retina evaluates inherited retinal disease in San Jose and Gilroy. If you have a diagnosis of retinitis pigmentosa, unexplained night blindness, progressive peripheral vision loss, or a family history of inherited retinal disease, schedule a retinal evaluation.

South Bay Retina is also conducting an investigational pilot study for eligible adults with documented retinitis pigmentosa. Study treatments are investigational, and their safety and effectiveness for RP have not been established. Ask our study team about current eligibility and research information.


 
 
 

Comments


© 2026 South Bay Retina. All Rights Reserved

bottom of page